The beneficial function of HDAC-6 inhibition against neurodegenerative diseases was demonstrated in AD trough the inhibition of Tau phosphorylation [99] in SOD1G93A mouse model of ALS [100,101] and in iPSC-derived motor neurons from ALS patients with FUS mutations [102]. This evidence concerns the gene MAPT and amyotrophic lateral sclerosis.